Placebo-adjusted mean weight loss of 11.3% (27.3 lbs) with 120 mg dose in the 36-week Phase 2b ACCESS study with a 10.4% adverse event-related ...
The recent discovery of over 100 previously unknown structures in Peru’s Rio Abiseo National Park has shed new light on the ...
NAXS AB ( ($SE:NAXS) ) just unveiled an announcement. NAXS AB has repurchased 13,170 of its own shares between December 1 and December 5, 2025, as ...
One year after its inauguration, Georgetown's Race, Power, and Justice course has evolved, but continues to stand by DEI.